Journal of Clinical and Experimental Investigations

• Chobanian AV. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878–87.
• Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women. Hypertension 2005;46:280-6.
• Ashton N: The eye in malignant hypertension. Trans Am Acad Ophthalmol Otolaryngol. 1972; 76:17–40.
• Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP and Diez J. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation. 2000;101:1729-35.
• Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91:250–6.
• Basaran Y, Tigen K, Karaahmet T, et al. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography. 2011;28:62–8.
• Das MK, Suradi H, Maskoun W, et al. Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis. Circ Arrhythm Electrophysiol. 2008;1:258–68.
• Park SJ, On YK, Kim JS, et al. Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot. Am J Cardiol. 2012;109:110–5.
• Homsi M, Alsayed L, Safadi B, et al. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2009;14:319–26.
• Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary arter disease. Circulation. 2006;113:2495-501.
• Gunn RM: On ophthalmoscopic evidence of general arteopathy: a review of existing classification systems and a sugrial disease. Trans Ophthalmol Soc UK 1898; 18:356–81.
• Gunn RM: Opthalmocsopic evidence of (1) arterialchanges associated with chronic renal diseases and (2) of increased arterial tension. Trans Ophthalmol Soc UK 1892;12:124–5.
• Ashton N: The eye in malignant hypertension. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:17–40.
• Ashton N, Peltier S, Garner A: Experimental hypertensive retinopathy in the monkey. Trans Ophthalmol Soc UK 1969;88:167–86.
• Pueyo V, Ara JR, Almarcegui C, Martin J, Güerri N, Garcia E et al. Subclinical atrophy of the retinal nerve fiberlayer in multiple sclerosis.Acta Ophthalmol. 2013;88:748–52.
• Kirbas S, Turkyilmaz K,Anlar O,Tufekci A, Durmus M. Retinal nerve fiber layer thickness in patients with Alzheimer disease . J Neuro-Ophthalmol. 2013;33:58–61.
• Oshitari T, Hanawa K, Adachi-Usami E. Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond). 2009;23:884-9.
• Sugimoto M, Sasoh M, Ido M, Wakitani Y, Takahashi C, Uji Y. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica. 2005;219:379–85.
• Park HY , Kim IT , Park CK .Early diabetic changes in the 25. nerve fi bre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol. 2011;95:1223-8.
• Shahidi AM, Sampson GP, Pritchard N, Edwards K, Vagenas D, Russell AW, et al. Retinal nerve fiber layer thinning associated with diabetic peripheral neuropathy. Diabet Med. 2012;29:e106–e111.
• Kong M, Kwun Y, Sung J,Ham D and Song Y M. Association between systemic hypertension and macular thickness measured by optical coherence tomograph. Invest Ophthalmol Vis Sci. 2015;56:2144– 50.
• Sahin O, Sahin S B, Ayaz T, Karadag Z, Turkyılmaz K, Aktas E, Bostan M. The impact of hypertension on retinal nerve fiber layer thickness and its association with carotid intima media thickness Blood Pressure, 2015; 24: 178–84.
• Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072.
• Peter W Wood, Jonathan B Choy, Navin C Nanda, Harald Becher. Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method. Echocardiography. 2014 Jan;31(1):87–100.
• Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography. European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
• Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462–536.
• Pietrasik G, Zaręba W. QRS fragmentation: diagnostic and prognostic significance. Cardiol J. 2012;19(2):114-21.
• Hayreh SS. Ischemic optic neuropathy. Progress in Retina and Eye Research. 2009;28(1):34-62.
• Stehouwer CD, Henry RM and Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008;51:527-39.
• Valensi P, Paries J and Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications – the French multicenter study. Metabolism 2003;52:815–820.
• Xu L, Zhou JQ, Wang S, et al. Localized retinal nerve fiber layer defects and arterial hypertension. Am J Hypertens. 2013;26(4):511-7.
• Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 1992;13(Suppl D):82-8. 22.
• Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992;13(Suppl D):66-9.
• Bayramoğlu A, Taşolar H, Bektaş O, Yaman M, Kaya Y, Özbilen M, Kaya A. Association between metabolic syndrome and fragmented QRS complexes: Speckle tracking echocardiography study.J Electrocardiol. 2017;50(6):889-93.

Vancouver

Doğan T, Yetim M, Kalçık M, Kocamış Sİ, Dönmez O, Bekar L. The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension. J Clin Exp Invest. 2019;10(1):em00719. https://doi.org/10.5799/jcei/5758

APA

Doğan, T., Yetim, M., Kalçık, M., Kocamış, S. İ., Dönmez, O., & Bekar, L. (2019). The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension. Journal of Clinical and Experimental Investigations, 10(1), em00719. https://doi.org/10.5799/jcei/5758

AMA

Doğan T, Yetim M, Kalçık M, Kocamış Sİ, Dönmez O, Bekar L. The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension. J Clin Exp Invest. 2019;10(1), em00719. https://doi.org/10.5799/jcei/5758

Chicago

Doğan, Tolga, Mucahit Yetim, Macit Kalçık, Sucattin İlker Kocamış, Oya Dönmez, and Lütfü Bekar. "The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension". Journal of Clinical and Experimental Investigations 2019 10 no. 1 (2019): em00719. https://doi.org/10.5799/jcei/5758

Harvard

Doğan, T., Yetim, M., Kalçık, M., Kocamış, S. İ., Dönmez, O., and Bekar, L. (2019). The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension. Journal of Clinical and Experimental Investigations, 10(1), em00719. https://doi.org/10.5799/jcei/5758

MLA

Doğan, Tolga et al. "The Relationship between the Retinal Nerve Fiber Layer Thickness and the Presence of Fragmented QRS Complexes in Patients with Hypertension". Journal of Clinical and Experimental Investigations, vol. 10, no. 1, 2019, em00719. https://doi.org/10.5799/jcei/5758